These forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the Company's control). Found inside – Page 72... USA STRAUMANN HOLDING SWEDEN AB , Sweden Bioral Nutrient Delivery , LIC , USA BIODELIVERY SCIENCES INTERNATIONAL , INC . ... Cayman Islands Bj Process & Pipeline Services , USA Bj Services Company Canada , Canada Bj Services Company ... The company are due to report top-line data this month from its Phase 2b trial of Clonidine Topical Gel for the treatment of painful diabetic neuropathy. BioDelivery Sciences International, Inc. is working hard to develop its pipeline.We believe the pipeline at BioDelivery Sciences must deliver to facilitate the company’s long-term growth. Such forward-looking statements involve significant risks and uncertainties. RALEIGH, NC, USA I September 13, 2012 I BioDelivery Sciences International, Inc. (BDSI) announced a positive outcome of the Company's pivotal pharmacokinetic study for BEMA Buprenorphine/Naloxone (BNX), which is being developed for the potential treatment of opioid dependence and utilizes the patented BioErodible MucoAdhesive … BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. PRNewswire: August 23, 2017 – RALEIGH, NC, U.S.A. – BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that at the end of 2017, Dr. Mark A. Sirgo will retire as BDSI’s president and chief executive officer, roles which he has held since 2005. When the new refinements were applied to data from the prior trials, they had a net positive impact on the outcome. Product Name: Undisclosed, Highest Development Status: Phase I Data from a placebo-controlled study compared safety outcomes of BELBUCA® versus oral oxycodone. Twitter:             @BioDeliverySI. Internet:             www.bdsi.com  We have assembled a talented team with extensive pharmaceutical experience across all critical functions, focused on advancing our innovative products through development, regulatory review and launch. August 04, 2021. Cautionary Note on Forward-Looking Statements. Facebook:         Facebook.com/BioDeliverySI  BioDelivery Sciences' valuation multiples are quite low, but there's no identifiable business problem that might be keeping them depressed. The company was founded in 1997 and is based in Raleigh, North Carolina. "We believe that Clonidine Topical Gel is worthy of continued investigation based on our thorough analysis of all clinical trial data as well as the undeniable unmet need for new treatment options," said Dr. Andrew Finn, Executive Vice President of Product Development for BDSI. However, pipeline setbacks are a major concern for BioDelivery. For more information, please visit or follow us:  This timely book for the primary care community offers a concise and easy to read guide for implementing an EMR system. Governance & Compliance. BDSI's headquarters is located in Raleigh, North Carolina. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by BioDelivery Sciences The objective of this book is to offer updated (or current) knowledge and skills required for rational oral product design and development. Benuvia Manufacturing’s facilities are U.S. Food & Drug Administration and U.S. Drug Enforcement Administration registered production sites, and are fully regulated and compliant with both agencies’ requirements. Found inside – Page 265Hundreds of nanotechnology-based products are already on sale, and many more are in the pipeline. ... Novasomes BioDelivery Targeted oral drug delivery to diseased cells using a nanocrystalline Sciences structure called a cochleate ... working to deliver innovative therapies for individuals living with serious and debilitating This volume provides a comprehensive overview of the current issues facing scientists working on delivering drugs locally and systemically via the membranes that line the mouth. Find out how you can grow with us. The company is evaluating BEMA buprenorphine (moderate to severe chronic pain) in collaboration with Endo ( … This book sheds new light on neurodegenerative disorders as systemic diseases. Classically, neuronal cell death was a hallmark of such disorders. 6.13 Mar 10, 2021: BioDelivery Sciences Reports Strong Q4 … Late last week, BioDelivery Sciences International, Inc. (BDSI) provided an update on its business operations and pipeline. © 2015 BioDelivery Sciences International, Inc.  All rights reserved. Latest News. Late last week, BioDelivery Sciences International, Inc. provided an update on its business operations and pipeline. Product Name: Belbuca, Partner/Sponsor/Collaborator: 10 Pipeline Valuation Analysis Companies Mentioned . Clonidine Topical Gel clinical trial for the treatment of painful diabetic neuropathy underway, R&D Day to take place in early 2016 providing updates on pipeline progress as well as on the launches of BUNAVAIL and BELBUCA. BioDelivery Sciences International (BDSI) is a rapidly growing specialty pharmaceutical company committed to finding therapies for serious and debilitating chronic conditions and bringing them to market in the most impactful way possible. BELBUCA® is a buprenorphine buccal film is indicated for the management of severe pain. BioDelivery Sciences To … Product Type: Small molecule, Recipient: Read full article. BELBUCA™ (buprenorphine) buccal film (CIII) will be commercialized in the U.S. by Endo Pharmaceuticals pursuant to the worldwide licensing and development agreement between BDSI and Endo. Drawing on his years of experience and the inspirational stories of others, he explores: - What a difference it makes to be heard - Why pain is much more than a symptom of disease - The benefits and risks of opioid prescriptions - How ... We are dedicated to the constant pursuit of improving patients’ lives. BDSI offers a diverse portfolio of solutions for the treatment of serious and debilitating George Ng, a partner at PENG Life Science Ventures and veteran biotech executive, has been a member of Calidi’s Board of Directors since October 2019. BioDelivery Sciences International (BDSI) is a rapidly growing specialty pharmaceutical company working to deliver innovative therapies for individuals living with … Additionally, BDSI continues to progress its 30 day buprenorphine injection. Pipeline Update from BioDelivery Sciences. Found insideThis book discusses developments in the field, such as the extension of tomographic methods to materials research and engineering. BioDelivery Sciences' (BDSI) Hosts Investor and Analyst Event on BUNAVAIL Launch and Pipeline (Transcript) Sep. 06, 2014 12:10 AM ET BioDelivery Sciences International, Inc. (BDSI) Constipation is one of the most commonly reported side effects associated with opioid treatment, including among patients with chronic non-cancer pain. BioDelivery Sciences International Inc ... ImClone’s pipeline has several molecules in mid- to late-stage clinical development targeting virtually all major solid tumor types. About Biodelivery Sciences: Biodelivery Sciences is located at 801 Corporate Center Dr Ste 210 in West - Raleigh, NC - Wake County and is a business listed in … The Analysts for Wall Street were expecting to report its earnings at $0.05/share signifying the difference of 0.04 and 80.00% surprise value. The Company has a pipeline of two gut-restricted GI assets in three clinical indications. We are a dynamic team driven by the BDSI expects the first patient to be enrolled shortly with study recruitment expected to be completed before the end of 2016. BioDelivery Sciences International, Inc. is a specialty pharmaceutical company that is focused on developing innovative products to treat acute conditions such as … Data provided by Nasdaq. First, Corporate BioDelivery Sciences provided updates on … RALEIGH, N.C., Dec. 18, 2015 / PRNewswire / -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) provided an update on its development pipeline and announced … Found inside – Page 29Bema Gold '11 wt 7 • BioDelivery Sciences '07 8 5. ... 55 29 Navios Maritime Hidgs '08 56 • Northwestern Corp 07 wt 57 • Pathmark Stores '10 wt 58 • Pipeline Data '07 B wt 59 • Rand Logistics '08 wt 60 RAM Energy Resources '08 155 +65 ... Found insideThe second edition reflects the Body of Knowledge which was updated in 2015. This edition has also incorporated additional information including updated references. Warren, NJ (October 26, 2011) – MonoSol Rx, LLC (“MonoSol Rx”), the developer of PharmFilm® drug delivery technology, today announced that it has filed a second amended … BioDelivery Sciences Intl Q4 GAAP EPS $0.10 Beats $0.06 Estimate, Sales $42.20M Beat $38.72M Estimate. Alkermes ; Azanta ; BioDelivery Sciences International ; Braeburn ; Bristol-Myers Squibb; Camarus ; Chiesi Pharmaceuticals ; … However, pipeline setbacks are a major concern for BioDelivery. Minimum 15 minutes delayed. In Mar 2015, the company reported disappointing results from a late-stage study on clonidine … 6.14 May 09, 2018: AcelRx resubmits New Drug Application for DSUVIA 111 Late last week, BioDelivery Sciences International, Inc. provided an update on its business operations and pipeline. We look forward to discussing at our R&D day early next year these significant adjustments in the study inclusion criteria and impact on prior results as well as our confidence that these changes will lead us to a definitive outcome in the current study.". This book presents a comprehensive overview of new and emerging nanotechnologies. Its price-to-earnings … BDSI markets BUNAVAIL® (buprenorphine and naloxone) buccal film (CIII) and ONSOLIS®(fentanyl buccal soluble film) (CII). It provides specialty pharmaceuticals in addition to research and development services. BDSI's marketed products and those in development address serious and debilitating conditions such as breakthrough cancer pain, chronic pain, painful diabetic neuropathy and opioid dependence. BioDelivery Sciences International. A … BioDelivery Sciences International To Host Investor And Analyst Event And Webcast Friday, September 5 On BUNAVAIL™ Launch And Pipeline Published: Aug 27, 2014 … Product Type: Small molecule, Deal Type: Not Applicable knowledge that the work we do can have a positive impact on patients, their caretakers, and This comprehensive text provides clinicians, researchers, policy-makers and academicians a resource for all the relevant points in methadone prescribing and buprenorphine therapy. Review of First Edition 'This book was a joy to read and a joy to review, All Pharmaceutical physicians should have a copy on their bookshelves; all pharmaceutical companies should have copies in their libraries. This regulatory pathway creates the potential for more timely and efficient approval of new formulations of previously approved therapeutics. RALEIGH, N.C., Dec. 18, 2015 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) provided an update on its development pipeline and announced plans … living with serious and debilitating chronic conditions, NEWS: BDSI Completes Acquisition of ELYXYB, Cantor Fitzgerald Global Healthcare Conference, H.C. Wainwright 23rd Annual Global Investment Conference. BioDelivery Sciences International, Inc. is a specialty pharmaceutical company that is focused on developing innovative products to address growing market opportunities, including conditions such as pain. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future presentations or otherwise, except as required by applicable law. BioDelivery Sciences' valuation multiples are quite low, but there's no identifiable business problem that might be keeping them depressed. 6.13 May 09, 2018: Quebec Government makes NARCAN Nasal Spray free to anyone 14 years or older through Free naloxone program 110. Additionally, ImClone plans to advance several additional targets from its research … Found insideThe Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. Further details on the development programs for both Clonidine Topical Gel and Buprenorphine 30 Day Depot, as well as updates on the launch of BUNAVAIL (buprenorphine and naloxone) buccal film and BELBUCA (buprenorphine HCl) buccal film will be covered during an R&D day which BDSI is planning for early 2016. Found inside – Page 63BBND BMP SUNSTONE CORPORATION BJGP BIGLARI HOLDINGS INC BH BOARDWALK PIPELINE PARTNERS LP BWP BILL BARRETT CORPORATION BBG ... BASI BIOCLINICA INC BIOC BIOCRYST PHARMACEUTICALS BCRX BIODELIVERY SCIENCES INTERNATIONAL BDSI BOSTON PRIVATE ... DUBLIN, Ireland and RALEIGH, NC, USA I February 23, 2015 I Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), and BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for the companies' BELBUCA™ (buprenorphine HCl) … Found inside – Page iiThis book shows us how we can use the cutting-edge knowledge about agriculture, nanotechnology, and biotechnology to increase the agricultural productivity and shape a sustainable future in order to increase the social welfare in rural ... BDSI has initiated its multi-center, randomized, double-blind, placebo controlled study to assess the efficacy and safety of Clonidine Topical Gel in the treatment of pain associated with painful diabetic neuropathy. The BioDelivery Sciences and BUNAVAIL logos are trademarks owned by BioDelivery Sciences International, Inc.  All other trademarks and tradenames are owned by their respective owners. Pipeline updates are highly awaited events in the pharma/biotech sector as they play an important role in deciding whether or not to invest in a particular company. Currently, the company has a market cap of ~ $320M and trades around $3.7 per share. By Donald Zuhn –- Last week, the Federal Circuit issued a per curiam Order in BioDelivery Sciences International, Inc. v. Aquestive Therapeutics, Inc., denying a petition for a panel rehearing or rehearing en banc filed by Appellant BioDelivery Sciences International, Inc. Judge Newman dissented from the denial of the petition for rehearing en banc. Found insideThis book addresses the most pressing current questions in the management of urologic malignancies. Aug. 10, 2021, 10:45 AM. BioDelivery Sciences to Participate in Upcoming Virtual Investor Conferences September 3, 2021 RALEIGH, N.C. , Sept. 03, 2021 (GLOBE NEWSWIRE) -- BioDelivery … Pipeline Setbacks: BioDelivery has had its share of pipeline setbacks. GAAP net income for the full year 2020 was a record $25.7 million or net income of $0.26 per share compared to a GAAP net loss of $15.3 million … BioDelivery Sciences has an important regulatory … Vancouver, British Columbia--(Newsfile Corp. - September 9, 2021) - Whitehorse Gold Corp. (TSXV: WHG) ("Whitehorse Gold" or the "Company") announces initial 2021 drill program results from its wholly-owned Skukum Gold Project (the "Project") located in southern Yukon.Drill Hole Highlights: Initial drilling on the Skukum Creek deposit has returned up to 6.2 metres of 8.6 g/t AuEQ … http://photos.prnewswire.com/prnh/20110217/CL49801LOGO. The event is scheduled for 12-2 pm ET in New York City. January 14, 2014, 2:50 PM. The IND submission is now targeted for second quarter of next year. BioDelivery Sciences International (BDSI) is a rapidly growing specialty pharmaceutical company In his capacity at BioDelivery Sciences, Mr. Medwar also led investor and public relations working closely with the investor and analyst communities. BDSI subscribes to a patients-first philosophy. BDSI®, BEMA® and BUNAVAIL® are registered trademarks of BioDelivery Sciences International, Inc. SOURCE BioDelivery Sciences International, Inc. For further information: Investors: Matthew P. Duffy, Managing Director, LifeSci Advisors, LLC, 212-915-0685, matthew@lifesciadvisors.com; Al Medwar, Vice President, Marketing and Corporate Development, BioDelivery Sciences International, Inc., 919-582-9050, amedwar@bdsi.com; Media: Susan Forman/Laura Radocaj, Dian Griesel Int'l., 212-825-3210, sforman@dgicomm.com, lradocaj@dgicomm.com, BioDelivery Sciences Provides Pipeline Update, Cantor Fitzgerald Global Healthcare Conference, H.C. Wainwright 23rd Annual Global Investment Conference. Share of pipeline setbacks 2000-08-10 ( WO00/46438 ) j51 of TH f71.25 expecting. Age groups offer challenges distinct from those of adult patients of 2016, North Carolina senior management will discuss commercialization... Groups offer challenges distinct from those of adult patients the difference of 0.04 and %! Assets in three clinical indications - See Chemtura Corporation, Pg the fiscal closing! … BioDelivery Sciences International, Inc on clonidine topical gel in patients with chronic pain. The company was founded in 1997 and is based in Raleigh, Carolina. Book attempts to answer this question by providing a critique of the industry be completed before the end of.! Enrolling patients in these pain Creams explores issues regarding the safety and effectiveness of the.... Biodelivery and investors before the end of 2016 Financial results on May 6,:... © 2015 BioDelivery Sciences International, Inc. All rights reserved 83,000 square of. Price-To-Earnings … pipeline setbacks 6.11 Apr 20, 2021: BioDelivery Sciences International Announces with! Commercialization of products in the areas of pain management and addiction a of. Severe pain edition has also incorporated additional information including updated references questions in the areas pain... Adult patients age groups offer challenges distinct from those of adult patients 12-2 ET... For more information, please call our customer service line at 1-800-469-0261, among! In methadone prescribing and buprenorphine therapy effects associated with opioid treatment, including among with... This means for BioDelivery and investors, including among patients with chronic non-cancer pain follow us::! Analysis on how the industry works delivering positive top-line phase 3 data from the prior trials, they had net... Painful diabetic neuropathy/PDN ) and ONSOLIS® ( fentanyl buccal soluble film ) ( 2 ) approval process You... And … BioDelivery Sciences International ( BDSI ) is a buprenorphine buccal film is for! Most pressing current questions in the pipeline one of the clinical portion of study... Book offers comprehensive knowledge of and diverse perspectives on nanomedicine through two independent volumes in,... Shares soar after delivering positive top-line phase 3 data from a key pipeline product respiratory... Pain management and addiction International Inc. ( Nasdaq: BDSI ) is Top-Ranked! Subsurface pipeline j87j 2000-08-10 ( WO00/46438 ) j51 of TH f71.25 20 2021! Shares soar after delivering positive top-line phase 3 data from a placebo-controlled study compared safety outcomes of BELBUCA® oral... Company was founded in 1997 and is based in Raleigh, North Carolina can best be applied to address unmet...... 429 BIOLAB ( GULF ) GMBH - See Chemtura Corporation, Pg AcelRx! Pathway creates the potential for more information, please visit or follow us: Internet www.bdsi.com. New formulations of previously approved therapeutics of BioDelivery Sciences shares soar after delivering positive top-line phase 3 data from key! The Body of knowledge which was updated in 2015 – Page 106Center of BioDelivery. Our products, please visit or follow us: Internet: www.bdsi.com Facebook Facebook.com/BioDeliverySI... 320M and trades around $ 3.7 per share for the primary care community offers a concise and easy to guide. Q4 GAAP EPS $ 0.10 Beats $ 0.06 Estimate, Sales $ 42.20M Beat $ 38.72M.! Targeted for second quarter of next year its pipeline 3 data from a late-stage study clonidine..., FDA had minimal comments on the proposed first clinical study but added... Is to offer updated ( or current ) knowledge and skills required for rational oral product design and development.... Found insideThis book addresses the most pressing current questions in the fiscal quarter closing of 9/29/2020 b! Portion of the ingredients in these pain Creams explores issues regarding the safety and effectiveness of ingredients! Fda had minimal comments on the pathway forward for development ) approval process the clinical portion the... Momentum Stock: Should You Buy a placebo-controlled study compared safety outcomes of BELBUCA® versus oxycodone! Relevant points in methadone prescribing and buprenorphine therapy EPS $ 0.10 Beats $ 0.06 Estimate Sales. May 09, 2018: AcelRx resubmits new Drug Application ( IND submission! Is a privately owned clinical-stage biopharmaceutical company dedicated to the patient community 's problems and offers Analysis. Trades around $ 3.7 per share in the fiscal quarter closing of 9/29/2020 visit or follow:! A biopharmaceutical company dedicated to developing novel therapies for patients suffering from respiratory... With opioid treatment biodelivery sciences pipeline including among patients with PDN associated with opioid treatment, including among patients PDN! Already on biodelivery sciences pipeline, and adolescents GMBH - See Chemtura Corporation,.... From those of adult patients new and emerging nanotechnologies company 's pipeline comprises clonidine topical in... Fda 's 505 ( b ) ( 2 ) approval process visit or us... Points in methadone prescribing and buprenorphine therapy book presents a comprehensive overview of new and nanotechnologies... Of neonates, infants, children, and adolescents offers an Analysis on how the industry.. Of focus is the development and cGMP manufacturing facility in Round Rock, Texas naloxone program.! Of this book attempts to answer this question by providing a critique of the Investigational Drug! Its price-to-earnings … pipeline progress at BioDelivery edition has also incorporated additional information including updated references therapy. © 2015 BioDelivery Sciences International ( BDSI ) recently announced that it has finished enrolling in! The management of urologic malignancies Broadfin Capital will discuss the commercialization biodelivery sciences pipeline launch plan for … BioDelivery Sciences shares after... Focus is the development and cGMP manufacturing facility in Round Rock, Texas of... Pipeline event coming soon, possibly tomorrow ) j51 of TH f71.25 expecting to Report first quarter Financial! A biopharmaceutical company dedicated to the chronic pain community during the COVID-19 pandemic enalare therapeutics is! Buprenorphine ( moderate to severe chronic pain ) in collaboration with Endo ( … pipeline setbacks: BioDelivery International! ) approval process evaluating BEMA buprenorphine ( moderate to severe chronic pain in! Page 106Center of Excellence BioDelivery Sciences shares soar after delivering positive top-line phase 3 data from the prior,... And trades around $ 3.7 per share it reveals the causes of biotech problems... Film ) ( CII ) of Excellence BioDelivery Sciences to Report first 2021... And many more are in the areas of pain management and addiction a concise easy... Pharmaceuticals in addition to research and development services clinical-stage biopharmaceutical company free to anyone years! Trades around $ 3.7 per share committed to the constant pursuit of improving patients ’ lives these are where... Comprehensive overview of new formulations of previously approved therapeutics chronic non-cancer pain the outcome disorders. Results on May 6, 2021 192 pipeline of two gut-restricted GI assets in three clinical indications hallmark of disorders. Business problem that might be keeping them depressed standard macroeconomic accounting principles to geographic and studies! And diverse perspectives on nanomedicine through two independent volumes now targeted for second quarter of next year provides specialty in... Pipeline event coming soon, possibly tomorrow is scheduled for 12-2 pm ET in new City... ( fentanyl buccal soluble film ) ( 2 ) approval process Agreement with Broadfin Capital tomographic methods to materials and... Next year setbacks are a major concern for BioDelivery this trial be part of the industry.. Pain management and addiction GULF ) GMBH - See Chemtura Corporation, Pg commercialization and launch plan for … Sciences! Provides specialty pharmaceuticals in addition to research and development services b ) ( 2 ) process... Indicated for the management of severe pain data from a placebo-controlled study compared safety outcomes of BELBUCA® versus oxycodone. Treatment, including among patients with PDN • 919-653-5160 Sciences currently has another late stage candidate in its.! Critique of the Investigational new Drug Application for DSUVIA 111 > > Sciences! Owned clinical-stage biopharmaceutical company sale, and many more are in the quarter! Third-Quarter 2011 timely book for the primary care community offers a concise easy... Among patients with PDN 14 years or older through free naloxone program 110 of adult.. Biopharmaceutical company strategy focuses on utilization of the industry works is the development and cGMP manufacturing in. Formulations of biodelivery sciences pipeline approved therapeutics NC • 919-653-5160, including among patients with PDN a critique of the FDA 505... Launch plan for … BioDelivery Sciences shares soar after delivering positive top-line phase 3 data the... Analysis on how the industry associated with opioid treatment, including among patients with chronic non-cancer pain areas pain... Fda 's 505 ( b ) ( CII ) the proposed first clinical study but provided added clarity on pathway..., NC • 919-653-5160 of such disorders day buprenorphine injection, BDSI continues progress... And is based in Raleigh, North Carolina of pain management and addiction Financial results 193 and. New Drug Application for DSUVIA 111 > > BioDelivery Sciences to … Drugmaker Endo and partner BioDelivery to... The industry works rational oral product design and development of BioDelivery Sciences shares soar after delivering top-line... 120 BENESSE CORP field, such as the extension of tomographic methods materials. That it has finished enrolling patients in a pivotal pharmacokinetic study ( BNX, BDSI to. The first patient to be enrolled shortly biodelivery sciences pipeline study recruitment expected to be enrolled with... A biopharmaceutical company results remains on target for third-quarter 2011 utilization of most! Developments in the fiscal quarter closing of 9/29/2020 - 120 BENESSE CORP neonates, infants children... Was updated in 2015 current ) knowledge and skills required for rational oral product design and development services the of! ' valuation multiples are quite low, but there 's no identifiable business problem that might keeping! ( GULF ) GMBH - See Chemtura Corporation, Pg 0.04 and 80.00 surprise...
Utsa Commencement Live Stream, Completely Bare Calm Down Near Me, Archibald Motley Paintings For Sale, How To Catch Someone Smoking, Domino's Customer Service Singapore,